Trial intelligence / Profile preview

Compound edaravone injection vs edaravone in acute ischemic stroke

CTR20150245Phase 3Completed

Sponsor
Simcere Pharmaceutical Group
Start
Apr 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of edaravone in ischemic stroke, sponsored by Simcere Pharmaceutical Group. Started Apr 2015; status: completed.

02

Drugs

edaravone
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on CTR20150245.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20150245.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call